Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Multiple Myeloma Advanced 2026

Noa Biran

诺阿·比兰

MD

🏢Hackensack University Medical Center / John Theurer Cancer Center(哈肯萨克大学医学中心/约翰·托伊尔癌症中心)🌐USA

Associate Professor of Medicine; Director, Myeloma Program医学副教授;骨髓瘤项目主任

34
h-index
2
Key Papers
4
Awards
2
Key Contributions

👥Biography 个人简介

Noa Biran, MD is Associate Professor of Medicine and Director of the Myeloma Program at Hackensack University Medical Center's John Theurer Cancer Center. A leading CAR-T cell therapy specialist in myeloma, she participated in the KarMMa trials of idecabtagene vicleucel and CARTITUDE studies of ciltacabtagene autoleucel, contributing to both approvals. She focuses on optimizing patient selection and managing toxicities of cellular therapies.

Share:

🧪Research Fields 研究领域

Idecabtagene Vicleucel KarMMa艾德基奥仑赛KarMMa
Ciltacabtagene Autoleucel西达基奥仑赛
CAR-T Cell MyelomaCAR-T细胞骨髓瘤
BCMA-Targeted TherapyBCMA靶向治疗
Myeloma Cellular Therapy骨髓瘤细胞治疗

🎓Key Contributions 主要贡献

Idecabtagene Vicleucel (ide-cel) Clinical Development

Served as site investigator for KarMMa and KarMMa-3 trials, contributing to FDA approval of ide-cel (bb2121) as the first BCMA-targeted CAR-T therapy for myeloma. Provided expertise on cytokine release syndrome management and bridging therapy optimization.

Real-World CAR-T Implementation in Myeloma

Led real-world studies of CAR-T outcomes at a high-volume academic center, defining predictors of response, durability, and toxicity in clinical practice outside trial settings, informing patient selection criteria and post-CAR-T monitoring protocols.

Representative Works 代表性著作

[1]

Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma (KarMMa)

New England Journal of Medicine (2021)

Phase II KarMMa trial demonstrating 73% ORR with ide-cel in heavily pretreated myeloma including 33% complete responses, supporting FDA approval of the first BCMA CAR-T therapy.

[2]

Real-World Outcomes of BCMA-Targeted CAR-T Cell Therapy in Multiple Myeloma

Blood Advances (2023)

Multicenter real-world analysis characterizing outcomes of ide-cel and cilta-cel in routine clinical practice, identifying factors predicting durable responses and early progression post-CAR-T.

🏆Awards & Recognition 奖项与荣誉

🏆ASH Abstract Achievement Award
🏆NCI Career Development Award (K23)
🏆John Theurer Cancer Center Research Excellence Award
🏆International Myeloma Society Young Investigator Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 诺阿·比兰 的研究动态

Follow Noa Biran's research updates

留下邮箱,当我们发布与 Noa Biran(Hackensack University Medical Center / John Theurer Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment